2021
DOI: 10.1021/acs.analchem.1c00426
|View full text |Cite
|
Sign up to set email alerts
|

In Situ Modulating DNAzyme Activity and Internalization Behavior with Acid-Initiated Reconfigurable DNA Nanodevice for Activatable Theranostic

Abstract: DNAzyme-mediated gene silencing was still challenged by off-target toxicity. In this study, we developed a split DNAzyme-based nanodevice (sDz-ND) that leveraged acidic tumor microenvironments to drive in situ assembly, thus modulating internalization behavior and silencing activity of DNAzymes. sDz-ND consisted of two different modules, which functionalized with split DNAzyme fragments, respectively. At psychological pH (∼7.4), the two modules were monodispersed, showing cleavage anergy and quenched fluoresce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

5
1

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 30 publications
1
7
0
Order By: Relevance
“…The split of the DNAzyme sequences was based on our previous report. 35 As expected in schematic (Figure S6A), the free therapy unit HP was able to cut the substrate EGR-1 mRNA into small pieces upon addition of Zn 2+ ions (Figure S6B), which proved the reasonable design of the sequence. The results were further explored by fluorescence assays (Figure S6C).…”
Section: ■ Results and Discussionsupporting
confidence: 65%
“…The split of the DNAzyme sequences was based on our previous report. 35 As expected in schematic (Figure S6A), the free therapy unit HP was able to cut the substrate EGR-1 mRNA into small pieces upon addition of Zn 2+ ions (Figure S6B), which proved the reasonable design of the sequence. The results were further explored by fluorescence assays (Figure S6C).…”
Section: ■ Results and Discussionsupporting
confidence: 65%
“…Currently, many nanocarriers (e.g., DNA tetrahedron, AuNPs, etc.) have been considered to protect DNA probes from nuclease degradation [28–32] . Thus, we envisioned whether 3D carriers based on Exos also had a similar capability.…”
Section: Resultsmentioning
confidence: 99%
“…have been considered to protect DNA probes from nuclease degradation. [28][29][30][31][32] Thus, we envisioned whether 3D carriers based on Exos also had a similar capability. To prove this concept, we measured the fluorescence recovery of the self-quenched hairpin H2 modified with cholesterol (termed H2-FQ) that anchored onto Exos in 10 % ultracentrifuged (UC) serum (ie, Exosdepleted fetal bovine serum).…”
Section: Resultsmentioning
confidence: 99%
“…Subsequently, we continuously developed acid-responsive assembly of multivalent nanotheranostics systems based on activatable strategy and successfully used to realize contrast-enhanced imaging of cancer cells. One is acid-activated reconfiguration of DNAzyme-based multivalent theranostics nanodevice for cancer cells imaging and gene therapy 38 . The other is pH-driven in situ constructed of activatable multivalent theranostics platform for intracellular TK1 mRNA activated cancer cells imaging and killing 39 .…”
Section: Introductionmentioning
confidence: 99%